LGND (Ligand Pharmaceuticals) FCF Margin % : 43.02% (As of Sep. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Ligand Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ligand Pharmaceuticals's Free Cash Flow for the three months ended in Sep. 2024 was $22.3 Mil. Ligand Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was $51.8 Mil. Therefore, Ligand Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2024 was 43.02%.

As of today, Ligand Pharmaceuticals's current FCF Yield % is 0.32%.

The historical rank and industry rank for Ligand Pharmaceuticals's FCF Margin % or its related term are showing as below:

LGND' s FCF Margin % Range Over the Past 10 Years
Min: -26.51 Med: 34.23 Max: 72.85
Current: 4.57

During the past 13 years, the highest FCF Margin % of Ligand Pharmaceuticals was 72.85%. The lowest was -26.51%. And the median was 34.23%.

LGND's FCF Margin % is ranked better than
81.91% of 1045 companies
in the Biotechnology industry
Industry Median: -145.32 vs LGND: 4.57

Ligand Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Ligand Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ligand Pharmaceuticals FCF Margin % Chart

Ligand Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-26.51

30.65

29.00

61.11

-3.25

Ligand Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															21.78	-151.88	52.24	26.91	43.02

Competitive Comparison of Ligand Pharmaceuticals's FCF Margin %

For the Biotechnology subindustry, Ligand Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ligand Pharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ligand Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ligand Pharmaceuticals's FCF Margin % falls into.

Ligand Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ligand Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4.272	/	131.314
	=	-3.25 %

Ligand Pharmaceuticals's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	22.289	/	51.812
	=	43.02 %

Ligand Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ligand Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ligand Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ligand Pharmaceuticals Inc (NAS:LGND) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

LGDN:Germany LGDN:Germany

Address

555 Heritage Drive, Suite 200, Jupiter, FL, USA, 33458

Website

https://www.ligand.com

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Executives

John L Lamattina	director	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Andrew Reardon	officer: CHIEF LEGAL OFFICER &	C/O LIGAND PHARMACEUTICALS INCORPORATED, 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO CA 92121
Matthew E Korenberg	officer: VP, Finance and CFO	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Octavio Espinoza	officer: Chief Financial Officer	C/O LIGAND PHARMACEUTICALS INC, 3911 SORRENTO VALLEY BOULEVARD, STE 110, SAN DIEGO CA 92121
Todd C Davis	director	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Nancy Ryan Gray	director	C/O LIGAND PHARMACEUTICALS INCORPORATED, 3911 SORRENTO VALLEY BOULEVARD, STE 110, SAN DIEGO CA 92121
Stephen L Sabba	director	DORSET MANAGEMENT CORP, 485 UNDERHILL BLVD SUITE 205, SYOSSET NY 11791
Martine Zimmermann	director	C/O LIGAND PHARMACEUTICALS INCORPORATED, 3911 SORRENTO VALLEY BOULEVARD SUITE 110, SAN DIEGO CA 92121
John W Kozarich	director	10275 SCIENCE CENTER DR, SAN DIEGO CA 92121
John L Higgins	officer: CEO & President	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Jason Haas	director	C/O SYROS PHARMACEUTICALS, INC., 35 CAMBRIDGEPARK DRIVE, CAMBRIDGE MA 02140
Matthew W Foehr	officer: EVP and COO	11119 NORTH TORREY PINES RD #200, LA JOLLA CA 92037
Jennifer R. Cochran	director	C/O LIGAND PHARMACEUTICALS INC, 3911 SORRENTO VALLEY BOULEVARD, STE 100, SAN DIEGO CA 92121
Charles S Berkman	officer: Asso. Gen. Counsel, Secretary	11085 NORTH TORREY PINES ROAD, SUITE 300, LA JOLLA CA 92037
Sunil Patel	director	11085 NORTH TORREY PINES RD., SUITE 300, LA JOLLA CA 92037